<DOC>
	<DOCNO>NCT02216838</DOCNO>
	<brief_summary>The purpose study find botulinum toxin A ( botoxÂ® ) use treat facial flushing . This study pilot study design determine feasibility procedure .</brief_summary>
	<brief_title>Treatment Facial Flushing With Botulinum Toxin A Injections</brief_title>
	<detailed_description />
	<mesh_term>Facies</mesh_term>
	<mesh_term>Flushing</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>1 . Patients 1865 year age persistent facial flush 2 . Willing ability understand provide inform consent participation study able communicate study staff . 1 . Unable understand protocol give inform consent 2 . Younger 18 old 65 year age 3 . Females pregnant lactate 4 . Known hypersensitivity BTXA 5 . Subjects use medication interfere neuromuscular function ( aminoglycoside antibiotic ) 6 . Subjects history congestive heart failure , carcinoid syndrome , mastocystosis , renal cell carcinoma 7 . Botulinum toxin injection past 6 month 8 . Ablative laser procedure past 6 month 9 . Radiofrequency device treatment past 6 month 10 . Ultrasound device treatment past 6 month 11 . Medium deep chemical peel past 6 month 12 . Temporary soft tissue augmentation material area treat past year 13 . Semipermanent soft tissue augmentation material area treat past 2 year 14 . Permanent soft tissue augmentation material area treat 15 . Is plan receive within next 6 month , cosmetic procedure ( chemical peel , botulinum toxin injection , ablative nonablative laser procedure , filler injection , radiofrequency procedure , dermabrasion , ultrasound face lift procedure ) forehead glabellar region . 16 . Is plan use tretinoin retinoic acid next 6 month 17 . Has active infection forehead glabellar region ( exclude mild acne ) 18 . Is allergic cow 's milk protein 19 . Is allergic albumin 20 . Is currently use anticoagulation therapy 21 . Has history bleeding disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>